Fibrin formation by wounded bronchial epithelial cell layers in vitro is essential for normal epithelial repair and independent of plasma proteins
M. J. Perrio
Institute of Biomedical and Biomolecular Sciences, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK
Search for more papers by this authorD. Ewen
Institute of Biomedical and Biomolecular Sciences, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK
Search for more papers by this authorM. A. Trevethick
Allergy and Respiratory Biology, Pfizer Global Research and Development, Sandwich, UK
Search for more papers by this authorG. P. Salmon
Allergy and Respiratory Biology, Pfizer Global Research and Development, Sandwich, UK
Search for more papers by this authorJ. K. Shute
Institute of Biomedical and Biomolecular Sciences, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK
Search for more papers by this authorM. J. Perrio
Institute of Biomedical and Biomolecular Sciences, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK
Search for more papers by this authorD. Ewen
Institute of Biomedical and Biomolecular Sciences, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK
Search for more papers by this authorM. A. Trevethick
Allergy and Respiratory Biology, Pfizer Global Research and Development, Sandwich, UK
Search for more papers by this authorG. P. Salmon
Allergy and Respiratory Biology, Pfizer Global Research and Development, Sandwich, UK
Search for more papers by this authorJ. K. Shute
Institute of Biomedical and Biomolecular Sciences, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK
Search for more papers by this authorSummary
Background The bronchial epithelium is in contact with, and continually damaged by, the environment. Animal models have indicated that normal epithelial repair is rapid and supported by the formation of a provisional fibrin matrix that is exclusively plasma-derived.
Objectives Our objectives were to demonstrate the ability of normal human bronchial epithelial (NHBE) cells to produce coagulation cascade proteins and form fibrin in response to damage, independently of plasma proteins, and to show that formation of a cross-linked fibrin matrix is essential for normal epithelial repair in vitro.
Methods Primary NHBE cells and cells of the 16HBE 14o- bronchial epithelial cell line were grown and maintained in vitro prior to mechanical wounding of confluent monolayers in serum-free media. Tissue factor (TF) and factor XIII (FXIII) were visualized on 16HBE 14o- monolayers using immunohistochemistry. The time-dependent expression of TF, factor VII (FVII), factor X (FX), fibrinogen, soluble fibrin, FXIII subunit A (FXIIIA) and D-dimers following wounding of confluent 16HBE 14o- monolayers was investigated using immunoassays. TF and FVII expression at the mRNA level was investigated by RT-PCR. The role of coagulation cascade proteins in the repair response of NHBE and 16HBE 14o- monolayers was investigated using neutralizing antibodies.
Results Active TF was constitutively expressed in 16HBE 14o- cells. Levels of FVII, FX, fibrinogen, soluble fibrin, FXIIIA and D-dimers in culture supernatants increased rapidly and were maximal 20 min after wounding the monolayers. Expression of TF and FVII mRNA was significantly increased 10 and 4 h, respectively, after wounding. Neutralizing antibodies to TF, fibrinogen and FXIIIA significantly inhibited repair of NHBE and 16HBE 14o- cell layers.
Conclusions The bronchial epithelium has the potential to respond rapidly to mechanical damage by forming a cross-linked fibrin matrix that is essential for normal epithelial repair, independently of plasma proteins.
References
- 1 Erjefalt JS, Persson CGA. Airway epithelial repair: breathtakingly quick and multipotentially pathogenic. Thorax 1997; 52: 1010–2.
- 2 Tesfaigzi Y. Processes involved in the repair of injured airway epithelia. Archiv Immunol Ther Exper 2003; 51: 283–8.
- 3 Persson CGA, Erjefalt JS, Greiff L et al. Contribution of plasma-derived molecules to mucosal immune defence, disease and repair in the airways. Scand J Immunol 1998; 47: 302–13.
- 4 Opal SM. Interactions between coagulation and inflammation. Scand J Infect Dis 2003; 35: 545–54.
- 5 Spronk HMH, Govers-Riemslag JWP, Ten Cate H. The blood coagulation system as a molecular machine. BioEssays 2003; 25: 1220–8.
- 6 Laplante AF, Germain L, Auger FA, Moulin V. Mechanisms of wound reepithelialization: hints from a tissue-engineered reconstructed skin to long-standing questions. FASEB J 2001; 15: 2377–89.
- 7 Kotton DN, Summer R, Fine A. Lung stem cells: new paradigms. Exp Hematol 2004; 32: 340–3.
- 8 Davies JC. New therapeutic approaches for cystic fibrosis lung disease. J R Soc Med 2002; 95: 58–67.
- 9 Mattoli S. Allergen-induced generation of mediators in the mucosa. Environ Health Perspect 2001; 109: 553–7.
- 10 Hackett T-L, Knight DA. The role of epithelial injury and repair in the origins of asthma. Curr Opin Allergy Clin Immunol 2007; 7: 63–8.
- 11 Holgate ST. Rhinoviruses in the pathogenesis of asthma: the bronchial epithelium as a major disease target. J Allergy Clin Immunol 2006; 118: 587–90.
- 12 Schoonbrood DFM, Out TA, Lutter R, Reimert CM, Van Overveld FJ, Jansen HM. Plasma protein leakage and local secretion of proteins assessed in sputum in asthma and COPD. The effect of inhaled corticosteroids. Clin Chim Acta 1995; 240: 163–78.
- 13 Jeffery PK. Remodeling and inflammation in bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004; 1: 176–83.
- 14 Barbato A, Turato G, Baraldo S et al. Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med 2006; 174: 975–81.
- 15 Idell S. Adult respiratory distress syndrome. Am J Respir Med 2002; 1: 383–91.
- 16 Ware LB, Camerer E, Welty-Wolf K, Schultz MJ, Matthay MA. Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury. Am J Physiol Cell Mol Physiol 2006; 291: L307–11.
- 17 Wagers SS, Norton RJ, Rinaldi LM, Bates JHT, Sobel BE, Irvin CG. Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness. J Clin Invest 2004; 114: 104–11.
- 18 Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Am J Pathol 1989; 134: 1087–97.
- 19 Morrissey JH. Tissue factor: an enzyme cofactor and a true receptor. Thromb Haemost 2001; 86: 66–74.
- 20 Sidelmann JJ, Gram J, Jespersen J, Kluft C. Fibrin clot formation and lysis: basic mechanisms. Semin Thromb Hemost 2000; 26: 605–18.
- 21 Ichinose A. Physiopathology and regulation of factor XIII. Thromb Haemost 2001; 86: 57–65.
- 22 Guadiz G, Sporn LA, Simpson-Haidaris PJ. Thrombin cleavage-independent deposition of fibrinogen in extracellular matrices. Blood 1997; 90: 2644–53.
- 23 Lwaleed BA, Francis JL, Chisholm M. Tissue factor assays as diagnostic tools for cancer? Correlation between urinary and monocyte tissue factor activity. J Hematother Stem Cell Res 1999; 8: 659–68.
- 24 Howat WJ, Holgate ST, Lackie PM. TGF-β isoform release and activation during in vitro bronchial epithelial wound repair. Am J Physiol Lung Cell Mol Physiol 2002; 282: L115–23.
- 25 Dugina TN, Kiseleva EV, Chistov IV, Umarova BA, Strukova SM. Receptors of the PAR family as a link between blood coagulation and inflammation. Biochem (Moscow) 2002; 67: 65–74.
- 26 Lan RS, Stewart GA, Henry PJ. Role of protease-activated receptors in airway function: a target for therapeutic intervention? Pharmacol Therapeut 2002; 95: 239–57.
- 27 Kazama Y, Pastuszyn A, Wildgoose P, Hamamoto T, Kisiel W. Isolation and characterisation of proteolytic fragments of human factor VIIa which inhibit the tissue factor-enhanced amidolytic activity of FVIIa. J Biol Chem 1993; 268: 16231–40.
- 28 Keller T, Salge U, Konig H, Dodt J, Heiden M, Seitz R. Tissue factor is the only activator of coagulation in cultured human lung cancer cells. Lung Cancer 2001; 31: 171–9.
- 29 Bach RR. Tissue factor encryption. Arterioscler Thromb Vasc Biol 2006; 26: 456–61.
- 30 Ahamed J, Versteeg HH, Kerver M et al. Disulfide isomerisation switches tissue factor from coagulation to cell signalling. Proc Natl Acad Sci 2006; 103: 13932–7.
- 31 Camerer E, Trejo J. Cryptic messages: is noncoagulant tissue factor reserved for cell signalling? Proc Natl Acad Sci 2006; 103: 14259–60.
- 32 Wilcox JN, Noguchi S, Casanova J. Extrahepatic synthesis of factor VII in human atherosclerotic vessels. Arterioscler Thromb Vasc Biol 2003; 23: 136–41.
- 33 Yamada T, Nagai Y. Immunohistochemical studies of human tissues with antibody to factor Xa. Histochem J 1996; 28: 73–7.
- 34 Nakata M, Kanekura S, Maruyama I. DX9065a, a Xa inhibitor, inhibits prothrombin-induced A549 lung adenocarcinoma cell proliferation. Cancer Lett 1998; 122: 127–33.
- 35 Bastarache JA, Wang L, Geiser T et al. The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor. Thorax 2007; 62: 608–16.
- 36 Hataji O, Taguchi O, Gabazza EC et al. Activation of protein C pathway in the airways. Lung 2002; 180: 47–59.
- 37 Simpson-Haidaris PJ. Induction of fibrinogen biosynthesis and secretion from cultured pulmonary epithelial cells. Blood 1997; 89: 873–82.
- 38 Lawrence SO, Simpson-Haidaris PJ. Regulated de novo biosynthesis of fibrinogen in extrahepatic epithelial cells in response to inflammation. Thromb Haemost 2004; 92: 234–43.
- 39 Adany R, Bardos H. Factor XIII subunit A as an intracellular transglutaminase. Cell Mol Life Sci 2003; 60: 1049–60.
- 40 Greenberg CS, Birckbichler PJ, Rice RH. Transglutaminases: multifunctional cross-linking enzymes that stabilise tissues. FASEB J 1991; 5: 3071–7.
- 41 Corbett SA, Schwarzbauer JE. Fibronectin–fibrin cross-linking. Trends Cardiovasc Med 1998; 8: 357–62.
- 42 Paye M, Lapiere CM. The lack of attachment of transformed embryonic lung epithelial cells to collagen I is corrected by fibronectin and FXIII. J Cell Sci 1986; 86: 95–107.
- 43 Takahashi H, Isobe T, Horibe J et al. Tissue transglutaminase, coagulation factor XIII and the pro-polypeptide of von Willebrand factor are all ligands for the integrins α9β1 and α4β1. J Biol Chem 2000; 275: 23589–95.
- 44 Sheppard D. Functions of pulmonary epithelial integrins: from development to disease. Physiol Rev 2003; 83: 673–86.
- 45 Upchurch HF, Conway E, Patterson MK Jr, Maxwell MD. Localization of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix bound enzyme. J Cell Physiol 1991; 149: 375–82.
- 46 Barry ELR, Mosher DF. Binding and degradation of blood coagulation factor XIII by cultured fibroblasts. J Biol Chem 1990; 265: 9302–7.
- 47 Rosenthal AK, Mosesson MW, Gohr CM, Masuda I, Heinkel D, Seibenlist KR. Regulation of transglutaminase activity in articular chondrocytes through thrombin receptor-mediated factor XIII synthesis. Thromb Haemost 2004; 91: 558–68.
- 48 Ewen D, Trevethick M, Salmon G, Shute J. A role for PAR-1 in bronchial epithelial repair. Eur Resp J 2005; 26: 556s.
- 49 Van Leer C, Stutz M, Haeberli A, Geiser T. Urokinase plasminogen activator released by alveolar epithelial cells modulates alveolar epithelial repair in vitro. Thromb Haemost 2005; 94: 1257–64.
- 50 Savla U, Appel HJ, Sporn PHS, Waters CM. Prostaglandin E2 regulates wound closure in airway epithelium. Am J Physiol Lung Cell Mol Physiol 2001; 280: L421–31.
- 51 Puddicombe SM, Polosa R, Richter A et al. Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J 2000; 14: 1362–74.
- 52 Zahm J-M, Debordeaux C, Raby B, Klossek J-M, Bonnet N, Puchelle E. Motogenic effect of recombinant HGF on airway epithelial cells during the in vitro wound repair of the respiratory epithelium. J Cell Physiol 2000; 185: 447–53.
- 53 Galiacy S, Planus E, Lepetit H et al. Keratinocyte growth factor promotes cell motility during alveolar epithelial repair in vitro. Exp Cell Res 2003; 283: 215–29.
- 54 Alpert SE, Walenga RW, Kramer CM, Silski CL, Davies PB. Tracheal epithelial cell fatty acid composition modulates prostaglandin E2 and cAMP production. Am J Physiol 1992; 262: L192–7.
- 55 Dewitt DL, Meade EA. Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes. Arch Biochem Biophys 1993; 306: 94–102.
- 56 Yin JY, Zhang J, Kumar A, Yu FX. Wound-induced ATP release and EGF receptor activation in epithelial cells. J Cell Sci 2007; 120: 815–25.
- 57 Bove PF, Wesley UV, Greul A-K, Hrsitova M, Dostmann WR, Van Der Vliet A. Nitric oxide promotes airway epithelial wound repair through enhanced activation of MMP-9. Am J Respir Cell Mol Biol 2007; 36: 138–46.
- 58 Erjefalt JS, Erjefalt I, Sundler F, Persson CGA. Microcirculation-derived factors in airway epithelial repair in vivo. Microvascular research 1994; 48: 161–78.
- 59 Greiff L, Andersson M, Erjefalt JS, Persson CGA, Wollmer P. Airway microvascular extravasation and luminal entry of plasma. Clin Physiol Funct Imaging 2003; 23: 301–6.
- 60 Pizzichini MM, Pizzichini E, Clelland L et al. Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Resp J 1999; 13: 15–21.
- 61 Nocker RET, Van Der Zee JS, Weller FR, Van Overveld FJ, Jansen HM, Out TA. Segmental allergen challenge induces plasma protein leakage into the airways of asthmatic subjects at 4 h but not at 5 minutes after challenge. J Lab Clin Med 1999; 134: 74–82.
- 62 Ovanesov MV, Ananyeva NM, Panteleev MA, Ataullakhanov FI, Saenko EL. Initiation and propagation of coagulation from tissue-factor-bearing cell monlayers to plasma: initiator cells do not regulate spatial growth. J Thromb Haemost 2005; 3: 321–31.
- 63 Gilmour PS, Morrison ER, Vickers MA et al. The procoagulant potential of environmental particles (PM10). Occup Environ Med 2005; 62: 164–71.
- 64 Shinagawa K, Martin JA, Ploplis VA, Castellino FJ. Coagulation factor Xa modulates airway remodelling in a murine model of asthma. Am J Respir Crit Care Med 2007; 175: 136–43.
- 65 Chatterjee A, Chauhan A, Vayro S, Shute JK. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in mild asthma. Am J Resp Crit Care Med 2004; 169: A453.
Citing Literature
